November 21, 2017

Women’s Health USA Poised for Growth – Goran Dragolovic named new Chief Executive Officer

The Women’s Health USA Board of Directors announced today the hiring of Goran Dragolovic as Chief Executive Officer. The move comes just a few months after Women’s Health USA completed a majority recapitalization with private equity firm Sverica Capital Management LLC (Sverica) in August and is a key piece in Women’s Health USA’s long-term growth initiative.

Goran comes to Women’s Health USA with more than 30 years of management and leadership experience in a broad range of healthcare service environments. Most recently, Goran spent nearly 7 years at Surgical Care Affiliates (SCA), and then at Optum after SCA was acquired by Optum. Goran served in several capacities there, including management of a $500M portfolio of surgery centers and specialty hospitals in the western US, leading enterprise-wide strategic service line expansion and, after the Optum transaction, Goran served as Senior Vice President of Practice Growth and Transformation for Optum. In that role, Goran helped aggregate and organize specialty and surgical physician groups into market-leading “CINs (clinically-integrated networks),” “High-performance IPAs,” and “Value-based Narrow Networks.” These groups were positioned to take advantage of innovative payment models on an episodic and population risk basis, either under upside gain-sharing arrangements, or on a full-risk basis. These arrangements empowered independent physicians to take greater control of value-based care delivery within their respective markets, ensured attendant economic benefits, and enabled physician groups to grow and thrive within the existing volatile healthcare market.

“Since Sverica’s investment in Women’s Health USA, the Sverica team has focused on a candidate worthy of our vision to replace retiring founder, Bob Patricelli. We found Goran to be extremely well-suited for the position.” said Dave Finley, Chairman of Board for Women’s Health USA. “His experiences will be highly complementary to the capabilities and expertise of the current Women’s Health USA senior executive team.”

Dragolovic adds, “There is a unique opportunity for OBGYN practitioners to become indispensable architects of value-based delivery models within their specialty, deliver on the triple aim, and transform the trajectory of women’s health. As a nationally recognized leader in women’s health with an impeccable reputation, clinical credibility and expertise, Women’s Health USA is uniquely positioned to lead efforts to assist physicians in seizing these opportunities.

I’m grateful and thrilled to join the remarkable team at Women’s Health USA and help lead our collective growth efforts.”

Women’s Health USA provides OBGYN, In Vitro Fertilization, and other specialty women’s health practices with a full suite of practice management solutions including payor contracting, revenue cycle management, EMR support, financial and human resource management, merger and acquisition support, ancillary services development, and risk management services. Women’s Health USA’s unique partnership model enables physicians and physician groups to maintain their independence, while leveraging the resources of a national organization.